Effect of nucleated cell count and cryopreservation on engraftment post autologous stem cell transplant


      Using 753 collections from 426 adult haematology patients, we conducted a retrospective, analysis into the effects of overnight storage and nucleated cell counts (NCC) on viable, CD34+ (vCD34+) recovery and engraftment kinetics post autologous stem cell, transplant (ASCT) with peripheral blood stem cells (PBSC). There were significant, differences in vCD34 + recovery ( P < 0.01) after cryopreservation associated with, the fresh NCC of ≥ 300 × 10 6 /mL in products stored overnight, but no association, with time to platelet or neutrophil engraftment post-ASCT was observed for these, products. There was no association of vCD34+ numbers or engraftment kinetics with cryopreserved NCC with either below or greater than the local recommended concentration of 400 × 106 /mL of product. However, there was significant difference in engraftment kinetics in relation to the viable CD34+ dose given at ASCT, in relation to the time to early engraftment and the amount of platelet support given during the engraftment period post-ASCT. We conclude the vCD34+ dose at ASCT is of great importance to early engraftment kinetics and that NCC is an important factor during overnight storage, but not for cryopreservation of PBSC. In light of our findings, we recommend that apheresis products collected in a closed system can safely be stored undiluted overnight.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Transfusion and Apheresis Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Trickett A. 5 Dec. 2015. Engraftment. [PowerPoint slides]. BMT 2017: 52;992 [accessed 2 February 2022].

        • Stewart D.A.
        • Guo D.
        • Luider J.
        • Auer I.
        • et al.
        Factors predicting engraftment of autologous blood stem cells: CD34+ subsets inferior to the total CD34+ cell dose.
        Bone Marrow Transplant. 1999; 23: 1237-1243
        • Perez-Smith J.A.
        • Martin A.
        • Caballero D.
        • Corral M.
        • et al.
        Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation.
        Bone Marrow Transplant. 1999; 24: 1279-1283
        • Siena S.
        • Schiavo R.
        • Pedrazzoli P.
        • Carlo-Stella C.
        Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy.
        J Clin Oncol. 2000; 18: 1360-1377
        • Parkins M.D.
        • Bahlis N.
        • Brown C.
        • Savoie L.
        • et al.
        Overnight storage of autologous stem cell apheresis products before cryopreservation does not adversely impact early or long-term engraftment following transplantation.
        Bone Marrow Transplant. 2006; 38: 609-614
        • Donmez A.
        • Cagirgan S.
        • Saydam G.
        • Tombuloglu M.
        Overnight storage of autologous peripheral progenitor stem cells without cryopreservation.
        Transfus Apher Sci. 2007; 36: 313-319
        • Lazarus H.M.
        • Pecora A.L.
        • Shea T.C.
        • Koc O.N.
        • et al.
        CD34+ selection of hematopoietic blood cell collections and autotransplantation in lymphoma: overnight storage of cells at 4°C does not affect outcome.
        Bone Marrow Transplant. 2000; 25: 559-566
        • Jansen J.
        • Nolan P.L.
        • Reeves M.I.
        • Akard L.P.
        • et al.
        Transportation of peripheral blood progenitor cell products: effects of time, temperature and cell concentration.
        Cytotherapy. 2003; 11: 79-85
        • Pamphilon D.
        • Mijovic A.
        Storage of hemopoietic stem cells.
        Asian J Transfus Sci. 2007; 1: 71-76
        • Makin R.
        • Cryopreserved H.P.C.
        Valid BMT Q-Pulse Qual Syst BMTCT Netw NSW. 5/03/2015;
        • Palladinetti P.
        Addit cryoprotectant BMT Q-Pulse Qual Syst BMTCT Netw Nsw 18/. 2020; : 08/
        • Keeney M.
        • Chin-Yee I.
        • Weir K.
        • Popma J.
        • et al.
        Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines.
        Cytometry. 1998; 34: 61-70<61::AID-CYTO1>3.0.CO;2-F
        • Morgenstern D.A.
        • Ahsan G.
        • Brocklesby M.
        • Ings S.
        • et al.
        Post-thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmes.
        Br J Haematol. 2016; 174: 942-951
        • Rowley S.D.
        • Bensinger W.I.
        • Gooley T.A.
        • Buckner C.D.
        Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation.
        Blood. 1994; 83: 2731-2736
        • Cabezudo E.
        • Dalmases C.
        • Ruz M.
        • Sanchez J.A.
        • et al.
        Leukapheresis components may be cryopreserved at cell concentrations without additional loss of HPC function.
        Transfusion. 2000; 40: 1223-1227
        • Martin-Henao G.A.
        • Torrico C.
        • Azqueta C.
        • Amill B.
        • et al.
        Cryopreservation of hematopoietic progenitor cells from apheresis at high concentration does not impair the hematopoietic recovery after transplant.
        Transfusion. 2005; 45: 1917-1924
        • Cordoba R.
        • Arrieta R.
        • Kerguelen A.
        • Hernandez-Navarro F.
        The occurrence of adverse events during the infusion of autologous peripheral blood stem cells is related to the number of granulocytes in the leukapheresis product.
        Bone Marrow Transplant. 2007; 40: 1063-1067
        • Bachier C.
        • Potter J.
        • Potter G.
        • Sugay R.
        • et al.
        High white blood cell concentration in the peripheral blood stem cell product can induce seizures during infusion of autologous peripheral blood stem cells.
        Biol Blood Marrow Transpl. 2012; 18: 1055-1060
        • Klein M.A.
        • Kadidlo D.
        • McCullough J.
        • McKenna D.H.
        • Burns L.J.
        Microbial contamination of hematopoietic stem cell products: Incidence and clinical sequelae.
        Biol Blood Marrow Transplant. 2006; 12: 1142-1149
        • Namdaroglu S.
        • Tekgunduz E.
        • Bozdag S.C.
        • Durgun G.
        • et al.
        Microbial contamination of hematopoietic progenitor cell products.
        Transfus Apher Sci. 2013; 48: 403-406
        • Antoniewicz-Papis J.
        • Lachert E.
        • Rosiek A.
        • Letowska M.
        Microbial contamination risk in hematopoietic stem cell products: retrospective analysis of 1996-2016 data.
        Acta Haematol Pol. 2020; 51: 29-33
        • Josefsson E.
        • Hartwig J.
        • Hoffmeister K.
        Platelet storage temperature – How low can we go.
        Transfus Med Hemotherapy. 2007; 34: 253-261
        • Rumjantseva V.
        • Hoffmeister K.
        Novel and unexpected clearance mechanisms for cold platelets.
        Transfus Apher Sci. 2010; 42: 63-70
        • Milford E.
        • Reade M.
        Comprehensive review of platelet storage methods for use in the treatment of active haemorrhage.
        Transfusion. 2016; 56: S140-S148
        • Cohn C.
        • Williams S.
        Cryopreserved platelets: the thaw begins.
        Transfusion. 2019; 59: 2759-2762